Otsuka Pharmaceutical

TRENTON, N.J | First drug approved for most common inherited kidney disease

TRENTON, N.J. | April 24, 2018 (AP)(STL.News)  The U.S. Food and Drug Administration has approved the first drug to slow kidney decline in patients with the most common inherited kidney disease. Jynarque (jihn-AR’-kew), from Japan’s Otsuka Pharmaceutical, was approved Tuesday for autosomal dominant polycystic kidney disease. The progressive genetic disorder is the fourth-leading cause of … Continue reading TRENTON, N.J | First drug approved for most common inherited kidney disease